Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of targeted cancer therapies. Its structure supports binding to specific enzyme active sites, making it valuable in designing drugs that modulate cellular signaling pathways. Also explored for its potential in central nervous system agents due to the presence of the methylpiperazine moiety, which enhances blood-brain barrier penetration. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates.